The role of mechano-regulated YAP/TAZ in erectile dysfunction
Abstract Phosphodiesterase type 5 inhibitors (PDE5is) constitute the primary therapeutic option for treating erectile dysfunction (ED).Nevertheless, a substantial proportion of patients, approximately 30%, do here not respond to PDE5i treatment.Therefore, new treatment methods are needed.In this study, we identified a pathway that contributes to ma